RESUMEN
Purpose: Echinacea purpurea (L.) Moench is a member of the Asteraceae family and is traditionally used mainly due to its immunostimulatory properties. Various compounds including alkylamides and chicoric acid were reported as active ingredients of E. purpurea. Here, we aimed to prepare electrosprayed nanoparticles (NPs) containing hydroalcoholic extract of E. purpurea using Eudragit RS100 (EP-Eudragit RS100 NPs) to improve the immunomodulatory effects of the extract. Methods: The EP-Eudragit RS100 NPs with the different extract:polymer ratios and solution concentrations were prepared using the electrospray technique. The size and morphology of the NPs were evaluated using dynamic light scattering (DLS) and field emission-scanning electron microscopy (FE-SEM). To evaluate the immune responses, male Wistar rats were administrated with the prepared EP-Eudragit RS100 NPs and plain extract in the final dose of 30 or 100 mg/kg. The blood samples of the animals were collected and the inflammatory factors and complete blood count (CBC) were investigated. Results: In vivo studies indicated that the plain extract and EP-Eudragit RS100 NPs (100 mg/kg) significantly increased the serum level of tumor necrosis factor-α (TNF-α) and interleukin 1-ß (IL1-ß) whereas the EP-Eudragit RS100 NPs (30 mg/kg) significantly increased the number of white blood cells (WBCs) compared to the control group. Lymphocytes' count in all groups was increased significantly compared to the control group (P<0.05) whereas other CBC parameters remained unchanged. Conclusion: The prepared EP-Eudragit RS100 NPs by electrospray technique caused significant reinforcement in the immunostimulatory effects of the extract of E. purpurea.
RESUMEN
The purpose of the study was to establish the psychometric properties of the Iranian-Children Participation Questionnaire (I-CPQ) among parents (n = 120) of preschool children with cerebral palsy. The mean age of the preschool children was 5.1 years old. The confirmatory factor analysis was conducted in two stages, and the values of all goodness of fit tests reached an acceptable level (greater than 0.9), and achieved an acceptable root mean square error of approximation model fit value of 0.05. The results of convergent validity with the Vineland Adaptive Behavior Scale for all subtests were significant. Internal consistency was acceptable to excellent (α: 0.66-0.85), and test-retest reliability was excellent (ICC: 0.92-0.98). We concluded that the I-CPQ demonstrated good psychometric properties and utility for assessing participation of Iranian preschool children with cerebral palsy.
Asunto(s)
Actividades Cotidianas , Parálisis Cerebral , Salud Infantil , Terapia Ocupacional , Padres , Calidad de Vida , Encuestas y Cuestionarios , Niño , Preescolar , Ambiente , Ejercicio Físico , Análisis Factorial , Femenino , Humanos , Irán , Aprendizaje , Masculino , Juego e Implementos de Juego , Reproducibilidad de los Resultados , Medio SocialRESUMEN
Nanocages (NCs) have emerged as a new class of drug-carriers, with a wide range of possibilities in multi-modality medical treatments and theranostics. Nanocages can overcome such limitations as high toxicity caused by anti-cancer chemotherapy or by the nanocarrier itself, due to their unique characteristics. These properties consist of: (1) a high loading-capacity (spacious interior); (2) a porous structure (analogous to openings between the bars of the cage); (3) enabling smart release (a key to unlock the cage); and (4) a low likelihood of unfavorable immune responses (the outside of the cage is safe). In this review, we cover different classes of NC structures such as virus-like particles (VLPs), protein NCs, DNA NCs, supramolecular nanosystems, hybrid metal-organic NCs, gold NCs, carbon-based NCs and silica NCs. Moreover, NC-assisted drug delivery including modification methods, drug immobilization, active targeting, and stimulus-responsive release mechanisms are discussed, highlighting the advantages, disadvantages and challenges. Finally, translation of NCs into clinical applications, and an up-to-date assessment of the nanotoxicology considerations of NCs are presented.